Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
Expert Review of Clinical Immunology|July 15, 2016
Prophylactic immunoglobulin therapy in secondary immune deficiency - an expert opinionCarlo Agostini, Igor-Wolfgang Blau, Eva Kimby, et al.
FEBS Letters|December 13, 2005
Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphomaJenny Flygare, Kristin Gustafsson, Eva Kimby, et al.
Annals of Hematology|August 19, 2020
Absolute B cell counts in blood predict long-term response in follicular lymphoma patients treated with rituximab without chemotherapyHenna-Riikka Junlén, Sandra Lockmer, Eva Kimby, et al.
Leukemia & Lymphoma|July 7, 2007
Characterization of genetic changes in MCL by interphase FISH on tissue sectionsBirgitta Sander, Ann Wallblom, Andrea Ekroth, et al.
British Journal of Haematology|September 11, 2018
Prognostic factors and primary treatment for Waldenström macroglobulinemia - a Swedish Lymphoma Registry studyLena Brandefors, Beatrice Melin, Jack Lindh, et al.
Seminars in Oncology|May 25, 2006
Strategies in the management of alemtuzumab-related side effectsAnders Osterborg, Claes Karlsson, Jeanette Lundin, et al.
Acta Oncologica (Stockholm, Sweden)|July 9, 2008
Cost-effectiveness of maintenance rituximab treatment after second line therapy in patients with follicular lymphoma in SwedenFrida Kasteng, Martin Erlanson, Hans Hagberg, et al.
Medical Oncology (Northwood, London, England)|August 20, 2005
Signaling molecules and cytokine production in T cells of patients with B-cell chronic lymphocytic leukemia (B-CLL): comparison of indolent and progressive diseaseShahryar Kiaii, Aniruddha Choudhury, Fariba Mozaffari, et al.
Pageof 12